Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × KRAS G12V Mutant Advanced Epithelial Cancers × Cyclophosphamide × Clear all

Status

Temporarily not available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Leukemia 1 KRAS G12V Mutant Advanced Epithelial Cancers 1 Immunoproliferative Disorders 1 Immune System Diseases 1

Interventions

pembrolizumab 1 Insulin Infusion Systems 1 Gemcitabine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡